Charlotte J. Imianowski

A cell-based bioluminescence assay reveals dose-dependent and contextual repression of AP-1-driven gene expression by BACH2

K. Okkenhaug, Jingqing Yang, S. Walker, 2020, Scientific Reports.

A distal enhancer at risk locus 11q13.5 promotes suppression of colitis by Treg cells

Howard Y. Chang, Carly E. Whyte, S. Andrews, 2020, Nature.

BACH2 restricts NK cell maturation and function, limiting immunity to cancer metastasis

K. Okkenhaug, Jingqing Yang, Joseph C. Sun, 2022, The Journal of experimental medicine.

BACH2 drives quiescence and maintenance of resting Treg cells to promote homeostasis and cancer immunosuppression

K. Okkenhaug, T. Kurosaki, D. Tough, 2020, The Journal of experimental medicine.

Acquisition of suppressive function by conventional T cells limits anti-tumor immunity upon Treg depletion

Giorgia Alvisi, E. Voulaz, R. Roychoudhuri, 2023, Science Immunology.

IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy

N. Brewis, M. Lakins, Sarah K. Whiteside, 2024, Cancer research communications.

CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function

F. Tacke, K. Okkenhaug, A. Liston, 2021, Immunology.